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The clot which forms in drawn blood occasionally lyses spontaneously, a phenome- 
non which Dastre explained in 1893 by the discovery of a proteolytic enzyme in serum 
which will digest the fibrin matrix of dots  (1).  Because plasmin  (or fibrinolysin)  is 
always present in a  precursor form but is rarely active, the reasons for spontaneous 
appearance  of activity have been sought.  By use of the  simple test of watching  a 
blood clot for the occurrence of lysis, it has become evident that natural fibrinolytic 
activity  occurs  almost  exclusively  in  pathological  states  (2).  Use  of more  refined 
techniques  in recent years has added  little  to the  knowledge  of fibrinolysis in ~/vo. 
Clot lysis or other evidence of proteolytic activity has been observed in shock  (3), 
after traumatic injury or burns  (4, 5), in acute febrile infection (6), in chronic liver 
disease (7, 8), sometimes with cancer (9), after injection of ACTH (4)  or epinephrine 
(10), or with fever induced by pyrogens (11). Of normal persons only those who have 
performed severe physical exercise will show direct lytic activity (10). Fibrinolysis or 
proteolysis  has  been  described  during  experimental  anaphylaxis  (12),  but  its  im- 
portance  is undecided.  The possible function  of the  enzyme in  the above states  is 
entirely obscure, but in several other conditions it is postulated to be a direct cause of 
some of the manifestations of the disease. 
Mothers with severe premature separation of the placenta occasionally have com- 
plete loss of clottable fibrinogen, presumably because of digestion by the circulating 
fibrinolysin that  accompanies the  condition,  and the consequence  is severe bleeding 
(13,  14).  A similar hemorrhagic state occurring with widespread metastasis of cancer 
of the prostate has been correlated with the ability of prostatic  tissue to produce a 
fibrinolysin (15).  Streptococci produce a potent activator of the human enzyme, and 
the rapid spread of streptococcal cellulitis is thought to be due in part to the locally 
induced breakdown of enclosing fibrin deposits which are found at infected sites (15). 
The thin watery character of streptococcal pus is due also in part to activation of fibrin 
digestion by products of the bacteria (17). 
Much evidence, therefore, suggests that fibrinolysis is a basic~ physiologically 
important  process,  which requires a  fuller understanding  in order to complete 
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our picture  of several disease  states.  Despite widespread  interest  and many 
observations, however, elucidation of the role of fibrinolysis in any of the above 
conditions had not been forthcoming. This is due largely to the complicated 
nature of the lysing system, which needs quantitative observations of a  num- 
ber of components before a  proper evaluation can be attempted. The natural 
process of activation can be seen only in the stress conditions cited, and activa- 
tion in the test tube can be achieved solely by means that are essentially arti- 
ticial.  Such means, however, have resulted in fruitful studies of the enzyme's 
properties. 
The nomenclature of Christensen gives the name plasminogen to the inactive en- 
zyme precursor contained in the fl-giobulins  of all plasmas (18).  Certain activators 
convert it to an active protease called  plasmin, which can hydrolyze a  number of 
proteins and most particularly fibrin (16). Plasmin absorbs to fibrin and when so ab- 
sorbed it is protected against inhibitory agents and thus seems more active against 
fibrin than against other proteins (19). 
The process of conversion of plasminogen to plasmin is poorly understood. Activa- 
tion with the streptococcal activator, now usually called streptokinase (18), has been 
studied the most thoroughly. Streptokinase is almost specific for human plasminogen, 
activating only traces of plasminogen from other species.  However, when a  small 
amount of human globulin  is added to streptokinase, the resulting mixture activates 
the plasminogen of other species quite readily (20). The activating property of such a 
mixture is destroyed rapidly at acid pH (whereas plasmin is most stable at acid reac- 
tion), but after neutralization it can be restored by fresh addition of streptokinase 
(21). These facts suggest that activation by streptokinase is mediated by an activator 
present only in human plasma, so accounting for the ineffectiveness  of streptokinase 
alone in non-human sera. It is interesting to note that this activator property is always 
found associated with human plasminogen and remains in constant ratio to plasmino- 
gen during Kline's procedure of purification (22) ; hence, its existence as an entity dis- 
tinct from human plasminogen still needs proof. 
Miillertz has reported the appearance of an activator in the blood of individuals 
undergoing  electric  shock therapy or sudden anoxemic death.  This substance was 
found in the globulin fraction and was capable of activating either human or bovine 
plasminogen (23). 
Other activating materials that are not species-specific have been discovered  in 
urine (24), in a number of different tissues  (25), and in cultures of staphylococci (26). 
A number of organic solvents such as chloroform and ether are activators also (16). 
Spontaneous activation of partially purified plasminogen has been observed to occur 
irregularly in solutions  allowed to stand several days in the cold (25). 
An inhibitory substance is found in normal blood which either destroys or neutral- 
izes the hydrolytic property of active plasmin. This was once thought to be the same 
as the trypsin inhibitor of serum, but the studies of Shulman (27) and of Jacobsson 
(28) make this view unlikely. Inhibition of plasmin has variously been reported as a 
stoichiometric and immediate reaction  (29) or else  as slow and enzymatic (30),  a 
conflict in observations which has needed elucidation  but which suggests the existence 
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In  view of this  complicated scheme of proenzyme, enzyme, a  number of 
activators,  and  one or more iuhibitors,  it would  seem that  any attempt  to 
evaluate the significance of the plasminogen system would require, at a given 
time, the separate measurement of each of the components in order to under- 
stand their interplay. 
Methods of measurement which distinguish  between activators and plasmin itself 
have been difficult to devise. Fibrin digestion is the favorite method for determination 
of plasmin  and dots for this purpose are commonly formed from animal fibrinogen 
that is only partially purified.  A number of workers have shown that these dots are 
contaminated with plasminogen  from their animal  source  (20,  31).  Consequently, 
lysis may be induced not only by the plasmin  of the sample under test, but also by 
plasmin activated from the dot. Except when extreme care has been taken to obtain 
pure fibrin,  work based on lysis of fibrin fails to distinguish  between activator and 
plasmin and, therefore, has a limited value. 
It seems obvious that the extent of activation of the plasminogen in the blood would 
be of physiological  importance, yet the usual demonstration of dot lysis does not 
determine what proportion of the total plasminogen has become active. It should be 
pointed out that lysis of a dot in vitro can be accomplished by a minute proportion 
of the potential proteolytic activity of the blood, but that very small amounts of free 
plasmin in the circulation may be without much effect on the organism. Such considera- 
tions as these make quantitative measurements of both plasminogen and plasmin in a 
sample  of blood of paramount importance. 
Finally, the degree of plasmin inhibition has been studied only rarely in relation to 
effective proteolysis; even though it is evident that, since they are always present, 
inhibitors must modify the final significant activity. 
As an approach to the complicated problem of simultaneous measurement 
of a number of factors, a  quantitative and specific method for the stable pre- 
cursor, plasminogen, has been developed and is presented in this paper.  For 
this purpose, it was first necessary to remove inhibitors without loss of plas- 
minogen,  and  then to accomplish complete conversion to plasmin,  the only 
measurable form of the enzyme.  Complete activation of human  plasminogen 
has  been achieved with  streptokinase by use of appropriate  conditions, but 
for animal plasminogen more complicated means were needed. It was found 
possible, however, to activate animal plasminogen completely with a combina- 
tion of streptokinase and an activator in human globulin.  This system was 
adapted to quantitative measurement of guinea pig plasminogen and was also 
found to be suitable  for the assay  of the activator in  human  serum.  Once 
activated, plasmin was measured by its ability to hydrolyze a common protein, 
casein, and the activity is expressed in an arbitrary caseinolytic unit  I. As the 
casein assay seems adaptable to the measurement of any of the factors of the 
lysing system, this unit can be used as a  common measure for the activity of 
1  A preliminary report of these studies appeared in Fed. Proc., 1956, 15, 606. 426  PLASMIN  SYSTEM.  I 
each component.  The application  of these methods  to a  study of the plasmin 
inhibitors of the blood will be presented in a  later paper. 
Materials 
Cascin.--Severai lots of commercial casein proved unsatisfactory as delivered because of 
their content of substances that are soluble in trichloroacetic acid. The Hammarsten casein 
furnished by the Amend Chemical Co., New York, was found to be appropriate material for 
further purification. Fifty gin. of the dry powder was suspended in a liter of distilled water 
and stirred vigorously for an hour with a stirring device. The suspension was transferred to 
250 ml. centrifuge bottles and centrifuged for 10 minutes at 1500 R.P.~¢. The slightly turbid 
supernatant was decanted and discarded; each bottle was refilled with distilled water and the 
precipitate resuspended by vigorous stirring. Centrifugation was repeated and the supernatant 
discarded. Two hundred ml. of 95 per cent alcohol was added to each bottle and the contents 
made into a slurry which was poured into a large Buchner funnel and the alcohol was filtered 
off. While in the funnel, the precipitate was washed twice more with 95 per cent alcohol and 
three times with anhydrous ether. The ether was allowed to evaporate thoroughly from the 
casein and the powder was ground in a mortar. The casein was considered to be satisfactory 
when 2.0 ml. of a 2 per cent solution, precipitated by 3.0 mL of 10 per cent trichloroacetic acid, 
gave a supernatant fluid with an optical density at 280 In#, not greater than 0.080. Because 
there may be some variation in the digestibility of various preparations  of casein, several 
lots prepared as above were thoroughly drummed to make one large sample which was used 
for all the experiments described herein. 
To make a 4 per cent casein solution buffered at pH 7.4, 4.0 gin. of casein was suspended in 
about 70 ml. of borate-saline buffer,  pH 7.4, with vigorous stirring. 0.25 ml. ~ NaOH per gin. 
of casein was added to convert the casein to the sodium salt. Thirty minutes or more of vigorous 
stirring was required to complete solution. The solution was adjusted  to pH  7.4  by glass 
electrode by slow acldition of N Na0H. The volume was then brought to exactly 100 ml. by 
further addition of the borate-saline buffer. A small amount of insoluble material was removed 
by centrifugatlon. Casein solutions were stored in the refrigerator for about  1 week without 
preservative and then discarded. 
Buffer.--Borate-saline buffer, pH 7.4, as described by Palltzsch (32), was used throughout. 
This was prepared  by mixing 0.05 ~  sodium borate (19.108 gin. Na2B4Ov 10H~O per liter of 
distilled water) with 0.2 ~r boric acid-salt  solution (12.404 gin. HsBO3 and  2.925  gm.  NaC1 
per liter of distilled water) until pH 7.4 was obtained by glass electrode. Approximately 1.2 
parts borate solution to 8.8 parts boric acid-salt solution were required. 
Streptokinase.--All experiments described here were performed with a single lot of varidase 
(No. 2200--10173), a lyophilized mixture of streptococcal enzymes consisting of streptokinase, 
streptodornase, other protein, and phosphate buffer, kindly furnished by the Lederle Labora- 
tories Division, American Cyanamid  Co. This material  contained  about  4000  Christensen 
units of streptokinase per nag. 
Euglobulin Solution.--Plasminogen in human or guinea pig serum was separated from its 
inhibitors by precipitation in the euglobulin fraction. Serum was diluted 20-fold with distilled 
water, and the reaction was adjusted to pH 5.2 by glass electrode by addition of 0.5 per cent 
acetic acid with constant stirring. The resulting precipitate, after being allowed to ripen for 
30 minutes, was transferred to a  50 ml. centrifuge tube and centrifuged 10 minutes at 1500 
R.P.M. The supernatant was decanted and the tube was drained for several minutes. Any drops 
of fluid on the lip of the tube were wiped away with tissue. The precipitate was resuspended in 
borate-salh]e buffer to provide a  concentration suitable for the particular testing that was 
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Purified _P/azminogen.--Human plasma fraction HI was used as the starting material  s in 
preparation of plasminogen by Kline's method (33). The plasminogea powder was dried with 
alcohol and ether according to Cliffton  and  Cannamela (34).  The dried powder  dissolved 
readily in 0.0025 M HC1, in which solution it was stable and was found to be fully active 
after several weeks storage at 5°C. 
Spearopkotometer.--Optical density readings at 280 m~ were  obtained with a  Beckman 
model DU spectrophotometer using a Beckman  ultraviolet attachment and quartz cuvettes 
with a i cm. light path. 
MET~0DS  AND RESULTS 
1. Human Pl~mi~gen 
A simple caseinolytic  assay for trypsin has been described by Kunitz which measures 
the digestion products by their ability to absorb ultraviolet light after precipitation of 
undigested protein with trichloroacetic acid (35). As described by Remmert and Cohen 
(36), it was determined that plasmin digested casein sufficiently in a  short time to 
use Kunitz' principle for plasmin assays. The next step was to determine an appro- 
priate concentration of casein and digestion time which would provide a quantitative 
assay for plasmin in the amounts which may appear in the blood or other body fluids. 
The course of the digestion of casein in several concentrations over a period of 1 hour 
by the plasmin separated from an equal amount of serum is illustrated in Fig. 1. Up to a 
limit, increasing substrate concentration increases its digestion by a given concentra- 
tion of an enzyme. Although a 2 per cent final concentration of casein during digestion 
is not at this limit for plasmin, it is sufficiently high to provide a sensitive assay when 
a 30 minute incubation period is used. The active enzyme is quite stable in the presence 
of casein for more than 30 minutes so that deterioration during the time of assay is 
not a problem. As a result of these experiments, digestion of 1.0 ml. 4.0 per cent casein 
by 1.0 ml. of enzyme solution for 30 minutes at 37°C. was adopted and used as a 
method throughout these studies. 
Measurement  of plasminogen  or plasmin  requires  removal of  the  inhibiting or 
interfering substances of serum. This end has always been accomplished by precipi- 
tating the euglobulin from diluted serum by acidifying to pH 5.2 (37, 38). Reexamina- 
tion of this method  by the more refined means available to us showed, in several 
trials of the process, that the same amount of plasminogen was always precipitated 
with the euglobulin from a  given serum. The precipitate was free of detectable in- 
hibitor and by careful determination only a small amount of plasminogen, amounting 
to less than 1 per cent of the total, could be found in the supernatant fluid. 
In order to measure the total plasmin precursor in the euglobulin, complete activa- 
tion to plasmin becomes necessary without any loss of the newly active but rather 
labile enzyme during the process of activation. Trials of human globulin with several 
activators showed that the highest activities were obtained with streptokinase, because 
it can act within seconds and thus lead to complete activation before the unstable 
plasmin deteriorates greatly. Kline has pointed out that plasmin is quite stable in the 
Human fraction Ill supplied by E. R. Squibb and Sons, Corp., through the courtesy of 
Dr. J. N. Ashworth, Assistant Director of the Blood Program of the American National Red 
Cross. Concentt,  ation 
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Fro. 1. Increase in digestion products with time and concentration  of casein produced by s 
single concentration  of human euglobulin sctivsted with streptokinase.  Incubated st 37°C. 
Final concentration  of casein in digestion mixture indicated. 
TABLE I 
T~  Adivatlng  F~ffecJ of Streptokinase  on  the Proleolytio Precursor in  the Euglobulin from 
1.0 Ml. Normal Human Serum in tke Presence of 1.0 Ml. 4.0 per cent 
Casein (Duplicate Determination) 
Streptok/nase 
lag. 
1.5 
2 
4 
6 
10 
40 
60 
80 
Optical density of digestion products 
(28o n~) 
0.258 
0.349 
0.470 
0.511 
O. 297 
0.349 
0.476 
O. 507 
100 
200 
300 
600 
800 
1000 
0.526 
O. 532 
O. 547 
0.550 
0.537 
0.544 
0.528 
0.494 
0.451 
0.451 
0.520 
O. 536 
0.557 
O. 566 
0.547 
0.546 
0.544 
0.486 
0.469 
0.421 
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presence of casein (or other substrate) and that no enzyme can be lost when activation 
occurs with substrate present (39). Activation in the presence of casein was tested by 
the addition of varying amounts of streptokinase to a series of tubes containing human 
euglobulin already mixed with casein. 
Table I shows the optical density of the digestion products which resulted from 30 
minutes' incubation of each tube. Peak values were obtained with the use of 50 to 
100 #g.  of streptokinase  and  probably represent  almost instantaneous  activation, 
while the reduction in activity occurring with more streptokinase is due to inhibition 
by an excess. The optimal amount of streptokinase needed to secure all the potential 
activity of a given sample falls within rather narrow limits; and, until streptokinase 
becomes available as a pure substance, it will be necessary to redetermine the optimum 
with each new lot. 
As an alternative method of activation, the streptokinase was allowed to act for 
several minutes on the euglobulin before the casein substrate was added. In this case, 
less streptokinase  was needed, since such rapid activation was not required.  For in- 
stance, ff the varidase used for these experiments acted on the euglobulm for 5 minutes 
at 37°C. before the addition of casein, the activity from 10 to 20 #g. equalled that 
provided by 60 to 100 #g. in the previous experiment. The active enzyme was unstable 
at 37°; consequently, incubation for longer than 5 minutes before the addition of sub- 
strate  resulted in detectable loss of activity. However, when purified materials such 
as the plasminogen preparation described by Kline (33) were tested, the active enzyme 
was so labile in neutral salt solutions in the absence of the stabilizing substrate that 
significant loss occurred even in 5 minutes at 37 °. For this reason, activation in the 
presence of substrate with the larger amounts of streptokinase was adopted as a more 
general method. 
In order to prepare a standard plasmin curve for reference in comparing unknowns, 
proteolytic determinations were done on a series of dilutions of a globulin suspension 
from normal serum. These were activated  by the  optimal amount of streptokinase 
in the presence of casein. Fig. 2 shows the increasing optical density readings obtained 
with increasing amounts of serum euglobulin. As defined by Kunitz (35), a proteolytic 
unit is the activity which gives rise, under the conditions of the test, to an increase of 
1 unit of optical density at 280 n~u per minute of digestion. The specific activity of the 
serum globulin is obtained by drawing a straight line tangent to the first part of the 
curve as shown in Fig. 2. The slope divided by 30 minutes is the activity per ml. of 
serum, i.g., 
0.326 
27.1 X  10  -8 units/ml,  serum. 
0.4 X  30 
A new curve is then plotted, the ordinates of which are the same as in Fig. 2, while 
the abscissae are expressed in plasmin units,  1 ml. serum being equal to 27.1  X  l0  -s 
units. The data on the new curve can be employed as a general standard  curve for 
determination of human plasmin activity, provided the same casein and conditions of 
assay are used.  Fig. 3 shows a  standard curve for human plasmin and a  curve for 
guinea pig plasmin is superimposed. The difference between the two sets indicates that 
a  new curve must be constructed for each species.  The data in Fig. 2 indicate that 0.500 
o.~ 
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0.100  //  27.1xi0  "3  plantain  unto5 
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o'.2  0'.4  o'.6  d8  :.o 
Eu91obin  froction  of  ~umon sel,  um  (ml.) 
(PestoPecl to 5epttrn  volume) 
Fzo. 2. Optical  density  of digestion  products after  incubating  1.0 ml. 4.0 per  cent  casein 
with an equal  volume of  euglobulin  from normal human serum for  30 minutes at  37°C. Acti- 
vation  with streptokinase.  Duplicate determinations  on cuglobulin  from 0.5 ml. of  8 normal 
sera  indicated  by various  symbols. 
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Fzo. 3. Standard unit curve for human and guinea pig plasmin constructed as described in 
text. Human curve is from data in Fig. 2, guinea pig curve is from Fig. 4. 
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0.5 ml. of serum is an appropriate amount to use for routine assays; the optical densi- 
ties found by duplicate determinations on 8 normal sera are indicated. From these 
data the following method is suggested for routine use:-- 
Measurement of Human Plasminogen.--2.0 mI. human serum is diluted to 40 mi. with 
distilled water and brought to pH 5.2 with 0.5 per cent acetic acid. After 30 minutes,  the 
precipitate is separated by centrifugation for 10 minutes at 1500 R.P.•.  and redissolved in 4.0 
ml. borate-saline buffer. Purified plasminogen  is weighed and dissolved directly in 0.0025 M 
HC1. Three aliquots of 1.0 ml. are pipetted into 16 )< 100 ram. test tubes for duplicate deter- 
minations and one blank; 1.0 ml. of 4 per cent casein, pH 7.4, is added to each. A series of 
samples is placed in a  37  ° constant temperature bath and several minutes are allowed for 
equilibration. Then, serially, at 1/~ or 1 minute intervals 0.1 ml. of streptokinase solution of 
previously determined optimum concentration (see above) is added and mixed thoroughly. 
Each tube is allowed to incubate at 37°C. exactly 30 minutes and then 3.0 ml. of 10 per cent 
trichloroacetic acid is rapidly added to stop digestion and precipitate the undigested protein. 
A blank for each sample is made by adding trichloroacetic acid prior to the streptokinase. 
A Cornwall syringe pipetting  outfit is convenient for adding the trichloroacetic acid rapidly. 
At least 1 hour is allowed for completion  of precipitation  s, then the precipitated protein is 
separated by centrifugation. The precipitate, being bulky and adherent, will not ordinarily 
separate cleanly with one centrifugation; therefore, it is convenient to centrifuge once, decant 
the supernatant into a second tube and centrifuge again. The optical density of the crystal- 
clear supernatant is read at 280 na~ ha a spectrophotometer. After subtraction of the optical 
density of the blank, the activity of the sample in units is determined by reference to the unit 
curve already described. 
2. Guinea Pig Plasminogen 
Similar determinations of plasminogen  in  the  serum  of lower animals  are 
less simple because there is no  known in vitro activator that acts as rapidly 
on the serum of animal species as streptokinase does on human plasminogen. 
This  fact  has prevented  the useful  estimation of the plasminogen, in animal 
sera and thus hampered study of the lysing system in experimental animals. 
With the appearance of the report that a  mixture  of human  euglobulin and 
streptokinase results in a potent activator of certain animal sera (20), it seemed 
that its action might be sufficiently rapid to give complete activation of animal 
plasminogens. 
The guinea pig was chosen as representative of those species whose plasminogen is 
not readily activated by streptokinase. Preliminary experiments showed that quite 
high activities resulted from guinea pig euglobulin if the globulin from only 0.05 ml. 
human serum was used as co-activator with streptokinase. Further experiments in- 
dicated that whole human serum gave results similar to separated globulin and, in 
this small volume, did not furnish enough inhibitor to change the result materially. 
Likewise, the purified human plasminogen was rich in the activating property. 
Activation in the presence of substrate could not be used in this system, since 
amounts of human globulin sufficiently large to provide instantaneous activation would 
* At this point the precipitates may be stored overnight in the refrigerator. 432  PLASMIN SYSTEM. I 
also have had enough proteolytic activity to interfere seriously with the accuracy of 
the final determination. It seemed advisable, therefore, to allow activation to proceed 
for 5 minutes prior to addition of casein. Under these conditions, optimum activation 
was achieved with 10 to 20 #g. streptokinase and 0.05 ml. human euglobulin. The ac- 
tivity curve determined from a  series of dilutions of guinea pig euglobulin is shown 
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Fro. 4. Optical density of digestion products after incubating 1.0 ml. 4 per cent casein with 
euglobulin from normal guinea pig serum for 30 minutes at 37°C. Magnitude of correction 
applied  for activating system indicated by arrow at lower left. Human curve from Fig. 2 super- 
imposed in dotted lines. 
in Fig. 4. The relatively small proteolytic activity inherent in the activating system is 
indicated. These data were used to construct the standard guinea pig curve already 
shown in Fig. 3. It is a general standard curve for the activity of guinea pig plasmin and 
may be used for conversion of optical density readings to plasmin units after the 
necessary correction for the activating system has been applied. Guinea pigs had, on 
the average, 35.5 X  10  -8 units of plasmin per ml. serum. The procedure finally adopted 
is given in detail below. 
Measurement of Guinea Pig Plasrainogen.--The euglobulin precipitate from 2.0 ml. guinea 
pig serum is prepared and redissolved in 2.0 ml. buffer. 0.5 ml. aliquots are pipetted into 
each of three tubes to afford a set of duplicate determinations and one reagent blank. To 
each tube is added 0.5 ml. of human euglobulin in a 1-10 dilution from its concentration in pmzie  s.  NOP.~AN  433 
serum. It is essential  for control  purposes to determine the small  amount of proteolytic  ac- 
tivity  possessed  by the human globulin.  For this,  the guinea pig euglobulin  is omitted from 
several  tubes,  the volume being made up with borate  buffer.  After  equilibration  in a 37  ° 
water bath,  0.1 ml. streptokinase  solution  of the previously  determined optimal concentra- 
tion  is  added to  each tube.  Exactly 5 minutes is  allowed  for  activation,  then 1.0  ml. warmed 
casein  is added and proteolytic  activity  is determined as described  for the human system. 
The reading  of the appropriate  reagent  blank is  subtracted  from the optical  density  of  each 
tube  containing  guinea  pig  euglobulin,  as  well  as  from  each  tube  containing  only  the  activating 
system.  The latter  value  for  the  small  proteolytic  activity  of  the  added human system is  then 
subtracted  from the optical  density  of the tubes containing  guinea pig euglobulin.  The re- 
sulting  figure  is  a measure of  the  guinea  pig  plasmin alone.  These optical  densities  are trans- 
lated  into  plasmin units  by reference  to  a standard  curve  for  guinea  pig  plasmin as  described 
above. 
3. The Activator in Human Serum 
The constituent in human  serum that is  needed for the activation of anlrnal 
plasminogen  by streptokinase has naturally attracted interest since its de- 
scription (2).  Further elucidation of its  nature depends upon accurate measure- 
ment, so  it  seemed desirable to quantitate the  amount present in serum samples. 
For this,  it is possible to use the system described above for the measurement 
of guinea pig plasminogen, if one provides less  than enough human  serum for 
complete activation.  In this case, the activity achieved is a measure of the 
human  activating principle. 
It was found that,  with the optimal amount of streptoldnase,  0.02 ml. of any of 
several human sera tested would activate about one-half the plasminogen in 0.S ml. 
guinea pig euglobulin in  S minutes at  37  °.  Accordingly, two human scra,  one high and 
one low in activating ability,  were examined in an experiment in which increasing 
amounts (up to 0.02 hal.)  of serum were added to a constant amount of guinea pig 
euglobulin and strcptokinase.  The active  protease was determined after  S minutes at 
37  ° and the results  are illustrated  in Fig. S. A  direct  relationship  is demonstrated 
between the concentration of human serum and the plasmin activated. It might be 
expected that globulins from different  guinea pigs would vary in the rate  at which 
they are activated.  However, when globulins  from several  animals were tested  simul- 
taneously  with a single  human serum, the  plasminogen activated in  each  was the same. 
A  test  was devised which uses 0.S ml. of a 1-25 dilution  of unknown serum with 0.S 
ml. guinea pig globulin and 20/~g. of varidase. An arbitrary unit of activator was 
chosen and is defined as the amount of activator which will  activate i unit of  guinea 
pig plasmin in S minutes at 37°C. in the presence of streptokinase.  The units of new 
plasmin activated multipficd by the  dilution  of  serum equals the  units  activator  per  ml. 
serum. The experimental figures  for  some normal scra  axe shown in Fig.  S.  These give 
calculated  values of  525 to  780 X  I0  "-S  units  activator  per  ml. serum. 
It should be stated that measurements of activator do not clarify  its controversial 
status  as a separate substance. Combination of streptokinasc with either  plasminogen 
itself  or a sccond cofactor could explain our data on formation of activator.  These 
experiments mcrely indicate  an  accurate means for  estimating the  activating  property 
of human serum. There follows the method finally  adopted for routine purposes. 434  PLASMIN  SYSTEM.  I 
Measurement of Human  Activator.--Human  serum is  diluted  2S-fold  with borate-saline 
buffer, pH 7.4, and 0.5  ml. aliquots are pipetted into each of 3  tubes to provide duplicate 
determinations and one blank. To each is added 0.5 ml. of separated guinea pig euglobulin 
restored to serum concentration. The tubes are transferred to a 370C. water bath and allowed 
to come to temperature. To each tube, 0.1 ml. of streptokinase of the previously determined 
optimal concentration is added. Mter exactly 5 minutes for activation, 1.0 ml. of previously 
warmed casein is added. Mter exactly 30 minutes of incubation, 3.0 ml. of 10 per cent trichloro- 
acetic acid is added to each. Blanks are made by adding the trichloroacetic add prior to adding 
the streptukinase.  The corrected optical densities found on the dear supernatant  fluids are 
~  J2 
•  ~  ~  B no~mal~ 
"-"  10 
ff'l 
N  ~ 
I  I  l  1  I  I  l  I  I  I  I 
0.004  0.006  0.012  0.016  0.020 
HumQn  5ePum  (ml,) 
FIo. 5. Units of plasmin activity obtained from 0.5 ml. guinea pig euglobulin by varying 
amounts of two normal whole human sera after 5 minutes at 37°C. with streptokinase. Plas- 
ruin activated by 0.02 ml. portion of 8 normal human sera indicated at right. 
translated into plasmin units by reference to a standard guinea pig plasmin curve. The unit 
activity per tube is multiplied by 50 to obtain the number of activator units per ml. of serum. 
DISCUSSION 
The casein method reported here offers the particular advantage  that it can 
be used as a general  method for determination  of the several  factors in the 
lysing system, expressing each of them in a common system of arbitrary units. 
Application  of the same unit system to all the components  should be of value 
in the quantitative description  of their interactions.  Extension of the caseino- 
lytic assay  to the  estimation  of inhibitor  will be described  in a  subsequent 
paper. pmL~Y  s.  NORM~N  435 
Casein digestion for determination  of plasmin has been used a  number of 
times  before.  Christensen's  work  on  the  nature  of streptokinase  activation 
was so done (18),  however, that his method would be unsuitable for routine 
determinations because it requires the euglobulin from about 10 ml. of serum 
for a  single  determination.  Downie and  Cliffton  circumvented this  difficulty 
by incubating  the digestion mixture for 24 hours  (40).  Prolonged incubation 
incurs the risk of deterioration of the enzyme during digestion and introduces 
the necessity of preventing bacterial growth in a medium that favors multipli- 
cation. The assay of Remmert and Cohen uses activation by streptokinase in 
the presence of casein,  although the reasons for so doing were not stated (36). 
The optimal amount of streptokinase, however, was not worked out by these 
authors. It has been the most satisfactory assay to date, but never has been 
adapted for measurement of total plasminogen of blood samples or assay of 
animal  plasminogen.  While this work was in progress, Miillertz  reported an 
assay very much like ours which he used for work on the nature of activation 
by streptokinase. His paper, being concerned with other matters, did not deal 
with  complete activation  of human  or animal  plasminogen  for purposes  of 
assay in physiological conditions (41). 
Since the only known action of plasmin  that  has physiological  significance 
is the digestion of fibrin,  assays using fibrin  as a substrate theoretically would 
be the more desirable. In practice, preparation of fibrinogen free of contaminat- 
ing  plasminogen  is  quite  difficult.  Casein,  on  the  other  hand,  is  available 
cheaply in a well purified form free of enzymes and inhibitors. Reproducibility 
in a fibrin assay depends upon formation of clots that are uniform in size and 
density, a problem which has not been adequately solved.  Furthermore,  the 
usual method for measuring fibrin digestion is visual observation of clot lysis, 
and lysis time is too crude for a  satisfactory quantitative  test. Shulman has 
presented a clever approach to the last problem by tagging fibrin with I ~al and 
measuring  the  radioactivity released by digestion  (29).  In  this  assay,  also, 
contamination of the fibrin with plasminogen and the need for uniformity of 
clots are difficulties  which have not been met. 
Assays based on hydrolysis of synthetic esters of arginine  and lysine (42, 43) 
have recently been developed and show great promise. They are rapid, easily 
done, and quantitative.  At present,  their specificity for plasmin is in doubt, 
because  thrombin  (44)  and  the  first  component  of  complement  (45)  have 
both been shown to digest the same esters. When crude biological  fluids such 
as  serum  are used,  these methods may not measure plasmin  alone.  At  the 
present,  plasmin is the only enzyme in blood that has been found to digest 
whole proteins at neutral pH. 
The labile nature of plasmin and the presence of inhibitors in the blood make 
the accurate estimation of the active enzyme circulating in the blood at any 
particular  time peculiarly difficult.  The nature  of inhibitor  revealed by the 436  PLAS~II~ SYSTEM.  I 
investigation to be reported in the subsequent paper  indicates that progressive 
inhibition occurs in the test  tube after a  blood sample is obtained. Unfortu- 
nately, there are no means known to us for preserving the active enzyme either 
from its own instability or from the continuing action of inhibitors while the 
plasma or serum is being separated from the formed elements of the blood. 
On the other hand, if circulating activator were present at the time the blood 
was drawn, it is possible that activation of plasminogen could also continue 
in the test tube. The foregoing combination of facts indicates the error that 
is inherent in interpretation of direct proteolytic tests  on blood plasma  or 
serum. It seems that this difficulty will not be resolved readily. 
CONCLUSIONS 
A general assay method involving casein digestion is shown to be applicable 
for determination of several components of the plasmin system. 
Total plasminogen of human serum can be measured by use of sufficient 
streptokinase for instantaneous activation, accompanied by protection of the 
active plasmin with casein. 
Total plasminogen of guinea  pig  serum  can  be  measured after  complete 
activation with streptokinase in combination with human activator. 
The activator principle in whole human serum can be measured by its ability 
to activate guinea pig plasminogen. 
The author wishes to acknowledge  the help and advice of Dr. Merrill W. Chase in whose 
laboratory this work was done. 
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